高通量篩檢市場規模、佔有率和趨勢分析報告：2024-2030 年按產品/服務、技術、應用、最終用途、地區和細分市場進行的預測

High Throughput Screening Market Size, Share & Trends Analysis Report By Product And Services (Consumables), By Technology (Cell-based Assays), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2024年08月14日 | 出版商:

Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

高通量篩檢市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球高通量篩檢市場規模預計將達到416.7億美元，2024年至2030年複合年成長率為10.6%。

製藥公司擴大採用快速、精確的技術向市場推出新分子，預計將顯著提振市場。

高通量篩檢用於基於各種基礎（包括化學、藥物和遺傳反應）測試正在開發的分子。這些篩檢有助於根據即時結果和模擬分子與身體之間自然反應的近自然條件來設計和開發藥物。

此外，該方法可以使用在短時間內儲存和處理大量資料的資料儲存設備以及能夠處理完全自動化流程的必要硬體和軟體來完全自動化。

截至 2016 年，大約 55.0% 的高通量篩檢測試是基於細胞檢測進行的。基於細胞的測定主要由於其在細胞層面上獲得的結果以及途徑和機製而被使用。

這些測定範圍從包括細胞凋亡在內的細胞毒性測試到細胞代謝測定。另一項主要技術的引入是 3D 細胞培養的引入，它有助於模擬自然條件並為所執行的測試提供更準確的結果和反應。預計這一趨勢將在預測期內支持市場成長。

高通量篩檢市場報告亮點

該市場是由製藥公司之間不斷增加的引入新分子的競爭所推動的。
即時提供更好結果的 3D 細胞培養技術的出現將推動市場發展。
北美已成為該技術開發和實施的明顯熱點，佔據了相當大的市場佔有率。
由於需要新分子來治療各種疾病，預計亞太和拉丁美洲等新興地區的需求將在預測期內顯著成長。

2023 年及 2030 年高通量篩檢(HTS)市場佔有率（按地區）
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 丹麥
- 瑞典
- 挪威
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 泰國
拉丁美洲
- 巴西
- 阿根廷
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 南非
- 科威特

第9章競爭格局

主要市場參與企業的最新趨勢和影響分析
公司分類
企業熱力圖分析
公司簡介
- Agilent Technologies, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc
- Aurora Biomed Inc.
- Tecan Trading AG
- Promega Corporation
- Charles River Laboratories.
- Creative Biolabs.

簡介目錄

Product Code: GVR-2-68038-155-9

High Throughput Screening Market Growth & Trends:

The global high throughput screening market size is expected to reach USD 41.67 billion by 2030, registering a CAGR of 10.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of faster and accurate technology by pharmaceutical companies to introduce newer molecules in the market is anticipated to provide a significant push to the market.

High throughput screening is used for testing of molecules in development phase on various grounds such as chemical, pharmaceutical, and genetic reactions. These screenings help in drug design and development based on real-time results and near-natural conditions that mimic natural reactions between the molecule and the body.

Moreover, this method can be fully automated using the required hardware and software capable of handling a fully automated process along with data storage units that store and process a considerable amount of data in a short span of time.

As of 2016, approximately 55.0% of high throughput screening tests are carried out based on the cell-based assays. Cell-based assays are used majorly owing to the results that can be obtained at cellular levels along with pathways and mechanisms.

These assays range from cytotoxic tests, including apoptosis, to cell metabolic assays. One more major technology implantation is the introduction of 3D - cell culture, which can help mimic natural conditions that give more accurate results and reactions to tests carried on. This trend is estimated to support the growth of the market during the forecast period.

High Throughput Screening Market Report Highlights:

The market is driven by increasing competition between pharmaceutical companies to introduce novel molecules
Emerging 3D cell culture technology that provides better results in real-time is set to boost the market
North America emerged as the clear hotspot for the development and adoption of this technology and had a major share in the market
Emerging regions such as Asia Pacific and Latin America are set to witness considerable growth in demand over the forecast period driven by the need of newer molecules to cure various diseases

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. High Throughput Screening (HTS) Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. High Throughput Screening (HTS) Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. High Throughput Screening (HTS) Market: Product and Services Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. High Throughput Screening (HTS) Market: Product and services Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Consumables
- 4.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.3.1.1. Reagents & Assay Kits
    - 4.3.1.1.1. Reagents & Assay Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.3.1.2. Laboratory Equipment
    - 4.3.1.2.1. Laboratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Instruments
- 4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.4.1.1. Liquid Handling Systems
    - 4.4.1.1.1. Liquid Handling Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.4.1.2. Detection Systems
    - 4.4.1.2.1. Detection Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 4.4.1.3. Other Instruments
    - 4.4.1.3.1. Other Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. Services
- 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Software
- 4.6.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. High Throughput Screening (HTS) Market: Technology Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. High Throughput Screening (HTS) Market: Technology Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Cell-based Assays
- 5.3.1. Cell-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.1. Fluorometric Imaging Plate Reader Assays
    - 5.3.1.1.1. Fluorometric Imaging Plate Reader Assays Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.1.2. Clinical Applications
      - 5.3.1.1.2.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.1.3. In-vitro Studies
      - 5.3.1.1.3.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.2. Reporter Based Assays
    - 5.3.1.2.1. Clinical Applications
      - 5.3.1.2.1.1. Clinical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.2.2. In-vitro Studies
      - 5.3.1.2.2.1. In-vitro Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.3. 3D - Cell Cultures
    - 5.3.1.3.1. 3D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.3.2. Scaffold-based Technology
      - 5.3.1.3.2.1. Scaffold-based Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    - 5.3.1.3.3. Scaffold-free Technology
      - 5.3.1.3.3.1. Scaffold-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.4. 2D - Cell Cultures
    - 5.3.1.4.1. 2D - Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.5. Reporter-based Assays
    - 5.3.1.5.1. Reporter-based Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  - 5.3.1.6. Perfusion Cell Culture
    - 5.3.1.6.1. Perfusion Cell Culture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Lab-on-a-chip Technology (LOC)
- 5.4.1. Lab-on-a-chip Technology (LOC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. Label-free Technology
- 5.5.1. Label-free Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Ultra High Throughput Screening
- 5.6.1. Ultra High Throughput Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. High Throughput Screening (HTS) Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. High Throughput Screening (HTS) Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
6.3. Drug Discovery Programs
- 6.3.1. Drug Discovery Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Chemical Biology Programs
- 6.4.1. Chemical Biology Programs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Biochemical Screening
- 6.5.1. Biochemical Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Cell & Organ-based Screening
- 6.6.1. Cell & Organ-based Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. High Throughput Screening (HTS) Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. High Throughput Screening (HTS) Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
7.3. Pharmaceutical & Biopharmaceutical Companies
- 7.3.1. Pharmaceutical & Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Academic & Research Institutes
- 7.4.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Contract Research Organizations (CROs)
- 7.5.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6. Others
- 7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. High Throughput Screening (HTS) Market: Regional Estimates & Trend Analysis

8.1. High Throughput Screening (HTS) Market Share, By Region, 2023 & 2030 (USD Billion)
8.2. North America
- 8.2.1. North America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.2.2. U.S.
  - 8.2.2.1. U.S. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.2.3. Canada
  - 8.2.3.1. Canada High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.2.4. Mexico
  - 8.2.4.1. Mexico High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3. Europe
- 8.3.1. Europe High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.2. U.K.
  - 8.3.2.1. U.K. High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.3. Germany
  - 8.3.3.1. Germany High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.4. France
  - 8.3.4.1. France High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.5. Italy
  - 8.3.5.1. Italy High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.6. Spain
  - 8.3.6.1. Spain High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.7. Denmark
  - 8.3.7.1. Denmark High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.8. Sweden
  - 8.3.8.1. Sweden High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.3.9. Norway
  - 8.3.9.1. Norway High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4. Asia Pacific
- 8.4.1. Asia Pacific High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.2. China
  - 8.4.2.1. China High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.3. Japan
  - 8.4.3.1. Japan High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.4. India
  - 8.4.4.1. India High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.5. South Korea
  - 8.4.5.1. South Korea High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.6. Australia
  - 8.4.6.1. Australia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.4.7. Thailand
  - 8.4.7.1. Thailand High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5. Latin America
- 8.5.1. Latin America High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.5.2. Brazil
  - 8.5.2.1. Brazil High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.5.3. Argentina
  - 8.5.3.1. Argentina High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6. Middle East and Africa
- 8.6.1. Middle East and Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.2. Saudi Arabia
  - 8.6.2.1. Saudi Arabia High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.3. UAE
  - 8.6.3.1. UAE High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.4. South Africa
  - 8.6.4.1. South Africa High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.6.5. Kuwait
  - 8.6.5.1. Kuwait High Throughput Screening (HTS) Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
- 9.4.1. Agilent Technologies, Inc.
  - 9.4.1.1. Participant's Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Danaher Corporation
  - 9.4.2.1. Participant's Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. Thermo Fisher Scientific Inc.
  - 9.4.3.1. Participant's Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. PerkinElmer Inc.
  - 9.4.4.1. Participant's Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. Bio-Rad Laboratories, Inc
  - 9.4.5.1. Participant's Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. Aurora Biomed Inc.
  - 9.4.6.1. Participant's Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. Tecan Trading AG
  - 9.4.7.1. Participant's Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. Promega Corporation
  - 9.4.8.1. Participant's Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. Charles River Laboratories.
  - 9.4.9.1. Participant's Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. Creative Biolabs.
  - 9.4.10.1. Participant's Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Recent Developments/ Strategic Initiatives